Related Experiment Video

Updated: Jun 25, 2026

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

Stem cells for treating glioblastoma: how close to reality?

C David James, Webster K Cavenee

    Neuro-Oncology
    |February 25, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
    09:18

    Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

    Published on: July 16, 2018

    Related Experiment Videos

    Last Updated: Jun 25, 2026

    Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
    12:25

    Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

    Published on: January 7, 2014

    Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds
    09:18

    Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

    Published on: July 16, 2018

    Related Concept Videos

    Induced Pluripotent Stem Cells01:06

    Induced Pluripotent Stem Cells

    Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
    Somatic cells are...

    Articles linked to this work by shared authors, journal, and citation graph.

    Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    LMNA-PRKDC axis enhances DNA repair and promotes chemoresistance in glioblastoma.

    Cell death & disease·2025

    Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.

    Research square·2025

    A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.

    Proceedings of the National Academy of Sciences of the United States of America·2025

    The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.

    Neuro-oncology·2024

    Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus.

    Journal of cellular physiology·2024

    ESTRO, ESNR and EORTC consensus-based definition for MRI abnormalities after radiotherapy for intracranial central nervous system tumours.

    Neuro-oncology·2026

    Prospective consecutive genomic profiling defines the distribution of meningioma molecular alterations across demographic groups.

    Neuro-oncology·2026

    Abexinostat attenuates temozolomide-resistant glioma stem cells.

    Neuro-oncology·2026

    A Framework for Prioritizing Novel Agents in Malignant Peripheral Nerve Sheath Tumor Trials: A report from the Neurofibromatosis Clinical Trials Consortium.

    Neuro-oncology·2026

    PET RANO 1.0 vs. RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: a retrospective, comparative study.

    Neuro-oncology·2026

    How 'Sturgeon' guides the surgeon in pediatric neuro-oncology.

    Neuro-oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us